Contura

Contura (formerly known as Speciality European Pharma) is a healthcare technology company that specialises in the distribution and sale of healthcare products, both in pharmaceuticals and medical devices.

Contura / Speciality European Pharma is a privately owned, specialist pharmaceutical and medical device company with a key focus on urology. SEP work throughout Europe and beyond to market and improve its products available to treat urological conditions. SEP aims to be considered the partner of choice for companies seeking to register and market their urology products in Europe.

In April 2013, SEP acquired the Danish company, Contura.

Contura’s soft tissue fillers target both the medical and aesthetic markets, with the two main products being Bulkamid and Aquamid.

Bulkamid is a urethral bulking agent used in the treatment of female urinary stress incontinence. The procedure is performed under endoscopic control using the Bulkamid Urethral Bulking System (patents pending). Clinical studies have been successfully performed in Europe and more recently in the United states.

Aquamid is a soft volume filler used to rejuvenate the face and enhance facial features. To date, plastic surgeons, dermatologists and cosmetic physicians have treated more than a quarter of a million people with Aquamid. Aquamid is available through a network of distributors covering 40 countries.

Caution: Aquamid(R) and Bulkamid(R) are investigational devices in the United States and limited by Federal (or United States) law to investigational use. They are not available for sale in the United States.